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Background: The aim of this prospective study was to determine the prevalence of stenosis
within intracranial and extracranial arteries in patients before coronary artery bypass
surgery (CABG), to evaluate the inﬂuence of intracranial artery stenosis on neurological
outcome and to identify preoperative risk factors for these patients.
Methods: One hundred and seventy-ﬁve patients (71% males, mean age = 66.1) scheduled for
CABG were enrolled for extracranial Doppler duplex sonography, transcranial color-coded
duplex sonography (TCCS) and transcranial Doppler (TCD) examination.
Results: Twenty-six patients (14.7%) had extracranial stenosis or occlusion and 13 patients
(7.3%) intracranial vascular disease. Six patients (3.5%) had both extra- and intracranial
artery disease. The presence of peripheral artery disease and diabetes mellitus was a strong
risk factor for extracranial artery stenosis but not for intracranial artery stenosis, which
occurred independently also of typical atherosclerotic risk factors like age >70, male sex,
hypertension, hyperlipidemia, hyperhomocysteinemia, smoking habit, obesity (BMI > 30)
and waist to hip ratio >1. Functional neurological outcome of the patients with intracranial
arterial disease evaluated 7 days after CABG was the same as the patients without extra- and
intracranial stenosis. However, 12-months neurological follow-up revealed signiﬁcantly
more ischemic strokes in patients with intracranial artery stenosis compared to patients
without intracranial stenosis ( p = 0.015).
Conclusion: The occurrence of intracranial artery stenosis in CABG patients cannot be
predicted by well-known atherosclerotic risk factors and seems not to be associated with
perioperative stroke.
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Stroke is a feared complication of coronary artery bypass graft
(CABG) surgery, and despite the improvement in surgical
techniques in the last decade, its incidence currently is
estimated to be as high as 1.3% to even 4.3% [1]. Cerebral
ischemia during the CABG is usually evoked by hypotension–
hypoperfusion, embolic phenomena (cardiac or of the aorta),
thromboembolism of extracranial and intracranial vessels, or
most probably, by the combination of some of these factors [2].
It is well known, that the presence of carotid artery stenosis
signiﬁcantly increases the risk of perioperative stroke and
carotid evaluation is currently recommended prior to CABG
procedure, although there are still some controversies
surrounding prophylactic carotid stenosis management [3].
However, the relevance of intracranial artery stenosis in the
group of CABG patients is less clear, mostly because of
limitation of available data. In general, intracranial athero-
sclerosis is believed to be one of the main causes of ischemic
stroke and is frequently recognized in the patients with
widespread vascular disease. It accounts for about 8–10% of all
brain ischemic events. Patients with intracranial stenosis may
have a risk of recurrent stroke as high as 20% in the ﬁrst 2 years
despite best medical therapy [4,5].
Thus, we aimed to determine the prevalence of intracra-
nial artery stenosis in patients before elective CABG and to
evaluate the inﬂuence of intracranial stenosis on periopera-
tive neurological complications and long-time prospective
neurological outcome. We also tried to identify predictors
for cerebral artery stenosis in CABG patients.
Patients and methods
One hundred and seventy-ﬁve consecutive patients scheduled
for elective CABG (on the basis of coronary angiography), were
enrolled for carotid extracranial Doppler duplex sonography
and transcranial color-coded duplex sonography (TCCS)
(ESAOTE TECHNOS MPX), and transcranial Doppler (TCD)
examination (VIASYS SONARA). Patients without severe
coronary artery disease and with no adequate temporal
window on TCCS/TCD were excluded from this study.
At each examination, a questionnaire requesting informa-
tion on demographic background and medical history was
completed. Clinical information was obtained directly from
the patients and medical records at the time of ultrasound
examination. We investigated the presence or absence of
hypertension, diabetes mellitus, hyperlipidemia, peripheral
artery disease (PAD) and the habit of smoking. Subjects
were considered hypertensive if their systolic blood pressure
(assessed on repeated measurements) was ≥140 mmHg, if
their diastolic blood pressure was ≥90 mmHg or if they were
taking antihypertensive medication. Subjects were deﬁned
as diabetic if their fasting glucose level was ≥7.00 mmol/L
(126 mg/dL) at least twice within a 48 h interval or if they were
taking antidiabetic medication. PAD was assessed based on
the history of intermittent claudication deﬁned as pain in the
muscles of the leg with ambulation. They were classiﬁed
as smokers if they smoked at least one cigarette per day, asnon-smokers if they had never smoked or smoked shorter
than 2 years and quit smoking >1 years prior to examination.
Waist circumference was measured around the narrowest
point between the coastal margin and the iliac crest. Hip
circumference was measured at the level of the widest
diameter around the gluteal region. Waist-to-hip ratio
(WHR) is waist circumference divided by hip circumference.
BMI and WHR were calculated for each subject on the day of
ultrasound examination.
The neurological assessment before surgery consisted of
an interview and neurological examination. The patients were
reevaluated three times – 1 week after surgery (or earlier if
necessary), 6 months and 12 months later, and followed by
the same neurologist who performed the initial neurological
examinations (PL). Development of any case of stroke and
the ﬁnal neurological outcome at discharge were determined
(according to NIH Stroke Scale). Stroke was deﬁned as a new
and sudden onset of focal neurological deﬁcits lasting >24 h
with no apparent nonvascular causes.
The atherosclerotic risk factors were predeﬁned according
to the guidelines of the American Heart Association, The Third
Joint Force of European and other Societies on Cardiovascular
Disease Prevention in Clinical Practice [6,7] and our University
Hospital laboratory's reference values. To investigate the
relationship between the number of atherosclerotic risk
factors and extracranial or intracranial artery stenosis we
classiﬁed each patient according to the presence of single or
multiple risk factors. Patients were considered to be at risk
when one or more of criteria were fulﬁlled: total cholesterol
(T-Chol.) > 200 mg/dL, LDL-C > 135 mg/dL, high density cho-
lesterol (HDL-C) < 40 mg/dL, T-Chol./HDL ratio > 5, triglycer-
ides > 200 mg/dL, BMI > 30 kg/m2 as well as presence of
hypertension, diabetes and smoking habits.
The degree of stenosis in the extracranial segment of
internal carotid artery (ICA) and vertebral artery (VA) was
classiﬁed as normal ﬂow or <50% stenosis, 50–69% stenosis,
70–99% stenosis or occlusion. The degree of stenosis in the
intracranial segments of the ICA (iICA) and VA (iVA) as well
as the stenosis of the anterior cerebral artery (ACA), middle
cerebral artery (MCA), posterior cerebral artery (PCA) and
basilar artery (BA) were classiﬁed as normal ﬂow or <50% or
≥50% stenosis or occlusion. The ultrasound examinations
were performed by two neurologists (JW and PL, working in
consensus). Locations of stenosis were categorized as being
in the intracranial or extracranial vessels. The degree of the
stenosis was established based on the peak systolic velocity,
diastolic velocity and mean ﬂow velocity as previously
reported [8,9].
Univariate analyses were performed to assess the associa-
tion between the prevalence of extracranial artery stenosis
(EAS) and intracranial artery stenosis (IAS) with the possible
risk factors. First, all variables were analyzed using Fisher's
exact x2 and Mantel–Haenszel x2 tests as appropriate. The t-
test was used to compare ages. A multiple logistic regression
analysis was used to estimate independent effects of the
predictive variables on the cerebral arterial occlusive disease.
The analyses were performed separately for extracranial
cerebral arteries and intracranial arteries, with each prede-
ﬁned abnormality as a dependent variable and with possible
risk factors as independent variables. The level of signiﬁcance
Table 1 – Demographic data and vascular risk factors of the patients with extracranial artery stenosis (EAS) and intracranial
artery stenosis (IAS).
Characteristics No EAS/No IAS, N = 136 EAS, N = 26 p value IAS, N = 13 p value
Age (SD) 65.72  7.2 65.78  9.0 0.98 70.25  6.7 0.15
Sex Male (63.2%) Male (61.5%) 0.97 Male (61.5%) 0.96
Hypertension 110 (80.9%) 24 (92.3%) 0.76 11 (84.6%) 1.0
Diabetes mellitus 37 (27.2%) 13 (50%) 0.02 2 (18.2%) 0.52
Hyperlipidemia 29 (21.3%) 6 (23.1%) 0.80 2 (18.2%) 1.0
Homocysteine 15.58  4.1 mmol/l 16.2  6.2 mmol/l 0.99 12.83  3.7 mmol/l 0.26
Smoking 35 (25.7%) 10 (38.5%) 0.37 2 (18.2%) 0.52
PAD 23 (16.9%) 12 (46.1%) 0.003 2 (18.2%) 1.0
BMI 28.35  4.1 28.49  3.1 0.94 27.85  3.6 0.97
WHR 0.99  0.09 0.98  0.08 0.95 0.969  0.06 0.825
p < 0.05 (bold).
x2 test of association, t test or Mann–Whitney test for comparison of means. PAD – peripheral artery disease; BMI – body mass index (m2/kg);
WHR – waist to hip ratio.
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Statistica 7.0 PL was used to perform al statistical analyses.
Results
The patient group included 127 males and 48 females (mean
age, 66.1  8.6 years, age range 44–85 years). One hundred and
thirty-six patients (76.8%) had no hemodynamically signiﬁ-
cant changes in extra- and intracranial arteries, 26 patients
(14.7%) had extracranial stenosis or occlusion and 13 patients
(7.3%) presented intracranial vascular disease. Six patients
(3.5%) had both extra- and intracranial artery disease.
Demographic data and vascular risk factors of the patients
with EAS and IAS are shown in Table 1. Within EAS patients
we have found 13 carotid stenoses of 50–69%, 14 carotid
stenoses of 70–99%, ﬁve cases of carotid occlusion, one
vertebral stenosis over 50%, two vertebral occlusions and four
cases of subclavian steal syndrome. Half of the EAS patients
presented stenosis or occlusion within more than one artery.
Within IAS group three patients had MCA stenosis of more
than 50%, two patients had PCA stenosis more than 50%, four
patients presented occlusion of intracranial part of VA. We
have also noticed two patients with intracranial unilateralTable 2 – Correlations between coronary artery risk
factors and occlusive lesions in extracranial cerebral
supplying arteries.
Odds ratio 95%CI p value
Age >70 years 1.23 0.43–3.48 0.88
Male sex 0.93 0.32–2.73 0.58
Hypertension 2.83 0.62–12.77 0.25
Diabetes mellitus 2.67 1.14–6.30 0.02
Hyperlipidemia 1.61 0.40–6.45 0.63
Hyperhomocysteinemia 1.07 0.39–2.88 0.99
Smoking 1.80 0.74–4.34 0.23
PAD 4.21 1.72–10.27 0.003
BMI > 30 0.76 0.21–2.78 0.99
WHR > 1 1.19 0.47–2.97 0.81
p < 0.05 (bold).
PAD – peripheral artery disease; BMI – body mass index (m2/kg);
WHR – waist to hip ratio.ICA stenosis of more than 50% and two patients with proximal
BA stenosis of more that 50%. In total, 22% of all patients
presented with hemodynamically important changes in brain
supplying arteries.
According to univariate analyses the presence of PAD was
a strong risk factor for EAS in patients with severe coronary
disease (OR 4.21, 95%CI 1.72–10.27). However, IAS in CABG
patients occurred irrespectively of PAD (OR 0.89, 95%CI 0.18–
4.30). Similarly, the presence of DM was a risk factor for EAS
(OR 2.68, 95%CI 1.14–6.30) but not for IAS (OR 0.49, 95%CI 0.10–
2.30).
In our study typical atherosclerotic risk factors like age >70,
male sex, hypertension, hyperlipidemia, hyperhomocysteine-
mia, smoking habit, obesity (MBI > 30) and WHR > 1 were not
signiﬁcant risk factors neither for EAS nor IAS (Tables 2 and 3).
All patients with carotid stenosis equal or over 70%
underwent carotid stenting before CABG. One patient died due
to ischemic stroke that occurred just after surgery (non-stenotic
group patient). All patients with intracranial stenosis had
extremely careful monitoring of blood pressure to avoid brain
hypoperfusion. Functional neurological outcome of patients
with intracranial arterial disease evaluated 7 days after CABG
was the same as the patients without extra- and intracranial
stenosis. However, 12-months neurological follow-up revealedTable 3 – Correlations between coronary artery risk
factors and occlusive lesions in intracranial cerebral
supplying arteries.
Odds ratio 95%CI p value
Age >70 years 1.74 0.53–5.65 0.35
Male sex 1.20 0.31–4.6 1.0
Hypertension 1.3 0.27–6.22 1.0
Diabetes mellitus 0.49 0.10–2.30 0.52
Hyperlipidemia 0.67 0.14–3.20 1.0
Hyperhomocysteinemia 0.69 0.19–2.40 0.52
Smoking 0.52 0.11–2.49 0.52
PAD 0.89 0.18–4.30 1.0
BMI > 30 0.72 0.16–3.14 0.72
WHR > 1 0.48 0.10–2.37 0.46
PAD – peripheral artery disease; BMI – body mass index (m2/kg);
WHR – waist to hip ratio.
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events) compared to patients without intracranial stenosis
(one event) (OR 17.6, 95%CI 1.75–176.69) ( p = 0.015).
Discussion
Perioperative neurological injuries (stroke as well as cognitive
dysfunction) seem to be the most devastating complications of
CABG [1,10]. Stroke is classically characterized as a neurologi-
cal deﬁcit attributed to an acute focal cerebral, spinal or retinal
injury of a vascular origin, including cerebral infarction,
intracerebral hemorrhage and subarachnoid hemorrhage.
Ischemic stroke is the most common type observed in CABG
patients, however perioperative procedures sometimes pro-
voke brain hemorrhage [11]. Clinical symptoms of stroke
usually consist of dysphasia (inability to speak and under-
stand), one-side paresis, sensation disturbance, vision ﬁeld
deﬁcit or ataxia. Stroke is associated with the prolonged
hospitalization, altered quality of life and increased hospital
mortality [1,12]. In one study perioperative CABG stroke
determined a four-fold higher chance of death [13].
Previous studies have described numerous risk factors of
neurologic complications during CABG, for example, chronic
renal failure, previous stroke, advanced age, female gender,
impaired left ventricular function, carotid disease, diabetes
mellitus and atherosclerosis of the ascending aorta [14–16].
The current study suggests that the majority of strokes that
occur during CABG are caused by cerebral macroemboli and/or
cerebral hypoperfusion [11,17]. Possible sources of cerebral
macroemboli during CABG may be the carotid arteries,
ascending aorta, intracerebral arteries or intracardiac cavities.
Cerebral hypoperfusion is mostly seen in carotid artery disease
patients and may lead to stroke in watershed regions of brain
[18]. On CT or MRI scans watershed strokes appear as an area of
hypodensity between the middle and anterior cerebral artery
or the middle and posterior cerebral artery supplying territory.
The recent recommendations for carotid evaluation before
CABG suggest that carotid duplex ultrasonography should
be performed in patients with at least one of the following
features: age over 65, left main coronary stenosis, PAD, prior
transient ischemic attack (TIA) or stroke and carotid bruit [3].
However, there is lack of high quality evidence to guide-
decision making about revascularization in patients undergo-
ing CABG, and available guidelines are based on limited data in
this area of clinical practice [19]. Carotid revascularization is
recommended in patients scheduled for CABG when carotid
stenosis is symptomatic or bilateral [20,21]. Unilateral asymp-
tomatic carotid stenosis management before CABG is still
unsolved [19].
Cerebral perfusion pressure (CPP) is the key pressure
gradient causing blood brain perfusion (blood ﬂow to the
brain). It should be maintained over 60 mmHg to prevent
inadequate blood ﬂow and in consequence brain ischemia [22].
CPP is related to mean systemic blood pressure (MBP) and
intracranial pressure (ICP) [CPP = MBP–ICP]. ICP is almost
constant value and reaches up to 10–15 mmHg. Thus, based
on deﬁnition, CPP mostly relates to MBP. Under normal
circumstances (MBP between 70 and 150 mmHg and ICP about
10 mmHg), average cerebral blood ﬂow is relatively constantdue to cerebral vessel autoregulation. Additionally, proper
blood supply to the hypoperfused regions of brain may be
preserved by net of collateral ﬂow. Carotid stenosis place CABG
patients at higher risk of stroke due to the hypoperfusion or
embolization from carotid plaque or both of them, especially in
patients with poor brain collateral ﬂow. Gold et al. found fewer
neurological complications after CABG surgery when mean
arterial pressure during procedure was between 80 and
100 mmHg rather than between 50 and 60 mmHg [23]. Reduced
cerebral blood ﬂow during surgery might be a primary cause of
ischemic brain injury, or it could exacerbate injury by
impairing clearance of microembolisms [24].
In our center we recommend carotid revascularization in
all patients before CABG if stenosis is over 70% as a routine
practice. Carotid stenting is a favorable method as it is
described as safer procedure for hemodynamically unstable
patients [3]. The results of our study showed that 14.7%
patients presented with extracranial artery stenosis or occlu-
sion. According to univariate analyses PAD and DM were
strong risk factor for EAS. In our study typical atherosclerotic
risk factors like age >70, male sex, hypertension, hyperlipid-
emia, hyperhomocysteinemia, smoking habit, obesity
(BMI > 30) and WHR > 1 were not signiﬁcant predictors of
EAS in patients scheduled for CABG. Similar results were
reported previously, as in studies performed by Alkan et al. [25]
and Uehara et al. [26].
The intracranial vascular atherosclerosis is one of the
major causes of ischemic stroke. It is believed that it accounts
for about 10% of all brain ischemic episodes. The presence of
IAS brings a 20% risk of recurrent stroke in the ﬁrst few years
[4,5]. Ischemic stroke may result from hypoperfusion distally
to the site of stenosis or occlusion of the artery in case of acute
thrombosis. Moreover atheromatic plaque may close small
penetrating arteries (especially branches of MCA) and may be
the source of embolic material itself [25,27]. Intracranial
atherosclerotic stenosis is typically located within infraclinoid
portion of ICA and within the MCA, VA and BA. Intracranial
artery ﬂow evaluation before cardiac surgery is not a routine
practice and most patients are limited only to extracranial
artery examination. In this study we used Doppler Duplex
ultrasound examination to evaluate neck vessels as well as
intracranial brain circulation. Our study showed that in
contrast to extracranial occlusive lesions the presence of
IAS in CABG patients was not predicted by any of the evaluated
typical atheromatic risk factors.
The previous studies noted that compared to EAS, IAS does
not correlate as well with the known atherosclerotic risk
factors for coronary and peripheral vascular disease (i.e., male
sex, age, hypercholesterolemia). Bae et al. (2006) suggests that
the correlation between coronary atherosclerosis and extra-
cranial artery stenosis is stronger than that between coronary
atherosclerosis and intracranial artery stenosis [28]. Similarly,
peripheral vascular disease correlates stronger with extracra-
nial stenosis than intracranial stenosis. However, IAS is
commonly associated with certain races and geographic
variables (black race, Japanese and Chinese are more prone
to IAS). Similarly to Alkan et al., we did not ﬁnd any
correlations between the presence of intracranial occlusive
disease and incidence of typical risk factors [25]. Alternatively,
novel risk factors for atherosclerosis should be investigated.
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ischemic stroke caused by total occlusion of proximal
segment of MCA (no-EAS, no-IAS group patient). Seven days
after the CABG, neurological examination (assessed accord-
ing to NIHSS scale) did not reveal any new neurological
dysfunction in the rest of the patients. However, 12-month
follow up of all patients revealed signiﬁcant difference in
stroke occurrence between intracranial stenotic group (three
ischemic strokes) and non-stenotic group (one ischemic
stroke). The same neurological outcome of the patients with
intracranial stenosis and the patients without intracranial
vessel pathology shortly after surgery was surprising, but
may be partially explained by extremely careful monitoring
of the IAS patients during intraoperative and postoperative
period (especially for avoiding hypotension). Further, in
contrast to non-stenotic group, the intracranial stenosis
group was treated with dual antiplatelet therapy for 3
months after the surgery, what may be beneﬁcial for this
group of patients [29]. Such treatment could make some
biases between the groups but was recommended in our
center from initiation of the study. At present, short-time (up
to 90 days) dual antiplatelet therapy with clopidogrel and
aspirin is recommended in intracranial stenotic patients
with TIA/stroke [30]. We strongly believe that use of dual
antiplatelet therapy may be an effective strategy to further
reduce the risk of stroke in patients with intracranial artery
stenosis scheduled for CABG, but not for all populations.
Large observational study is required to address this
question.
Conclusions
A sizeable proportion of patients undergoing CABG surgery
was found to have extracranial and/or intracranial artery
disease. Our study showed that the presence of IAS does not
affect neurological outcome shortly after the cardiac surgery,
however it was a signiﬁcant risk factor for ischemic stroke
during the 1-year follow up. The lack of acute strokes during
the perioperative period in IAS patients may have partially
resulted from very careful hemodynamic monitoring during
the CABG surgery and within the next days. Despite the fact
that we did not ﬁnd any signiﬁcant correlation between the
presence of IAS and stroke occurrence during CABG surgery, it
seems reasonably to categorize such patients into a higher risk
group. Since TCD examination can evaluate the cerebral ﬂow
and indicate the patients with poor cerebral perfusion reserve,
we recommend this examination in all patients scheduled for
elective CABG.
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